Home › UPDATE 1-Vertex cystic fibrosis combo succeeds in key late-stage trials
 

Keywords :   


UPDATE 1-Vertex cystic fibrosis combo succeeds in key late-stage trials

2014-06-25 09:50:35| Biotech - Topix.net

A combination of Vertex Pharmaceuticals Inc's cystic fibrosis drug Kalydeco and its experimental lumacaftor succeeded in improving lung function in a pair of closely watched late-stage trials of patients with the most common genetic mutation associated with the rare lung disease.

Tags: key update combo trials

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.06Atlantic Tropical Weather Outlook
23.06Eastern North Pacific Tropical Weather Outlook
22.06AI and agriculture: A look at whats ahead
22.06Atlantic Tropical Weather Outlook
22.06Atlantic Tropical Weather Outlook
22.06Eastern North Pacific Tropical Weather Outlook
22.06This Week in Agribusiness, June 22, 2024
22.06This Week in Agribusiness, June 22, 2024
More »